Sequencing of Canine Parvovirus (CPV) from Rectal Swab Samples V.1
Sara França de Araújo dos Santos, Ueric José Borges de Souza, Martha Trindade Oliveira, Jairo Jaime, Fernando Rosado Spilki, Ana Cláudia Franco, Paulo Michel Roehe, Fabrício Souza Campos
Disclaimer
Abstract
Canine parvovirus (CPV) is a highly contagious viral disease that affects dogs, especially puppies. CPV-2 is recognized for its resilience in contaminated environments, ease of transmission among dogs, and pathogenicity for puppies. In this protocol, we have adapted the methodology to allow the recovery of complete CPV-2 genomes directly from clinical samples (dry swabs) from puppies with clinical signals of viral enteritis. A multiplex PCR was designed with primers targeting fragments of 400 to 1,000 base pairs (bp) along the full length of the viral genome. The resulting reads were compared after sequencing with the Nanopore technology. Genome assembly revealed that the smaller fragments generated larger numbers of reads, allowing a more reliable coverage of the genome than those attained with primers targeting larger amplicons. Both new methodologies were efficient in amplification and sequencing.
Steps
Nucleic Acid Extraction using Quick-DNA/RNA Viral MagBead (Zymo Research)
This protocol uses
All kit's solutions need to be prepared beforehand, as described by the kit. If you've already prepared the solution, go to step 2. This is a modified version of the kit's protocol. The original kit's protocol can be found here.
DNA/RNA Buffer:
Add 500µL
of beta-mercaptoehtanol (user supplied) per 100 ml Viral DNA/RNA Buffer , (final 0.5% (v/v)
DNA/RNA Wash 1:
Kit R2140 --> Add 20mL
of isopropanol (2-propanol PA, user supplied) to MagBead DNA/RNA Wash 1 concentrate
Kit R2141 --> Add 80mL
of isopropanol (2-propanol PA, user supplied) to MagBead DNA/RNA Wash 1 concentrate
DNA/RNA Wash 2:
Kit R2140 --> Add 30mL
of isopropanol (2-propanol PA, user supplied) to MagBead DNA/RNA Wash 2 concentrate
Kit R2141 --> Add 120mL
of isopropanol (2-propanol PA, user supplied) to MagBead DNA/RNA Wash 2 concentrate
DNA/RNA Shield™:
Kit R2140 --> Add 25mL
of nuclease-free water (user supplied) to 2X DNA/RNA Shield™ concentrate
Kit R2141 --> Add 125mL
of nuclease-free water (user supplied) to 2X DNA/RNA Shield™ concentrate
Proteinase K (20 mg/ml):
Kit R2140 --> Add 1.04mL
of Proteinase K Storage Buffer to lyophilized Proteinase K (20mg
)
Kit R2141 --> Add 3.12mL
of Proteinase K Storage Buffer to lyophilized Proteinase K (60mg
)
Mix by vortexing. Use immediately or store frozen aliquots.
Elute each dry Sample
into 400µL
of 1X viral DNA/RNA buffer.
Our samples were dry rectal swabs of animals confirmed positive by a rapid test.
Samples were collected and stored in a centrifuge tube (without transporting media) at -20 ºC until processing.
For each sample, add 10µL
of beads and 4µL
of proteinase K.
Obs: when working with many samples, one can always prepare a mixed solution with both components. Just make to keep the beads suspended while pipetting.
Transfer the plate (or your tubes) to magnetic stand (user supplied). After the beads have pelleted, aspirate and discard the supernatant.
This protocol can be fast tracked by the use of an automated extractor .
We use EXTRACTA 96 (Loccus).
Perform one wash of the pellet (beads) with 250µL
of MagBead DNA/RNA Wash 1 solution.
Perform one wash of the pellet (beads) with 250µL
of MagBead DNA/RNA Wash 2 solution.
Add 250µL
of 80% ethanol and mix well.
Transfer the sample (liquid and beads) to a new place/tube.
Pellet the beads and discard the the supernatant.
Add 50µL
of nuclease-free water and mix well (this is the elution step).
Pellet the beads (magnetically) and transfer the supernatant (containing DNA/RNA) to a new plate/tube.
Multiplex PCR to obtain CPV genome fragments
This protocol uses 2 sets of oligos: one set amplifies ~400 bp sequences that overlap about 100 nucleotides with each other (Table 1); the other amplifies ~1000 bp sequences that overlap about 100 nucleotides with each other (Table 2). Primers are listed in the tables below and were design based on Canine parvovirus reference sequence NC_001539.1 (GenBank).
Primers should be mix into 2 pools for each set. To prepare a pool, add 5µL
of each primer (at 100micromolar (µM)
) as indicated. This will be your 10X (stock) solution. Working solution should be dilute to 1X concentration (10micromolar (µM)
).
A | B | C | D | E | F |
---|---|---|---|---|---|
CPV-400_0.7_LEFT* | 1 | ATGTCTGGCAACCAGTATACTG | 22 | 45.50 | 60.30 |
CPV-400_1_LEFT | 1 | AACCAACTGACCAAGTTCACGT | 22 | 45.45 | 60.80 |
CPV-400_1_RIGHT | 1 | GTTCCAGCGAACATCCTTTCCA | 22 | 50.00 | 61.31 |
CPV-400_1.5_LEFT* | 1 | AGGTGGCGGGCTAATTGTG | 19 | 57.90 | 59.50 |
CPV-400_2_LEFT | 2 | AAGAAACATGCAGAAAATGAAGCATT | 26 | 30.77 | 59.73 |
CPV-400_2_RIGHT | 2 | CGTAGCCATTTACCAGTTGCTTG | 23 | 47.83 | 60.67 |
CPV-400_3_LEFT | 1 | ATGGGGAAAAGATCAAGGCTGG | 22 | 50.00 | 60.81 |
CPV-400_3_RIGHT | 1 | AGTGTGCTGACAATTTGTCTGTC | 23 | 43.48 | 59.94 |
CPV-400_4_LEFT | 2 | GGGTGACTATATTAACATACAGACATAAGC | 30 | 36.67 | 60.59 |
CPV-400_4_RIGHT | 2 | TCCTGGTTGTGCCATCATTTCA | 22 | 45.45 | 60.68 |
CPV-400_5_LEFT | 1 | ACTTTGCGGGACTTGGTTAGTA | 22 | 45.45 | 59.81 |
CPV-400_5_RIGHT | 1 | ACAACCAACATTACCCACAGCT | 22 | 45.45 | 60.61 |
CPV-400_6_LEFT | 2 | CAGTTCTTTTTCATGGACCAGCA | 23 | 43.48 | 59.93 |
CPV-400_6_RIGHT | 2 | AAACCAAAGTCTCCTGGAAGCT | 22 | 45.45 | 60.01 |
CPV-400_7_LEFT | 1 | TGGATGTGAAGAAAGACCTGAACA | 24 | 41.67 | 60.47 |
CPV-400_7_RIGHT | 1 | AACGCCAAGTTGGTTTGATTGT | 22 | 40.91 | 60.01 |
CPV-400_8_LEFT | 2 | AGTGGACCTTGCACTGGAAC | 20 | 55.00 | 60.20 |
CPV-400_8_RIGHT | 2 | GCTTCGTCGTGTTCTTTTGCAG | 22 | 50.00 | 61.33 |
CPV-400_9_LEFT | 1 | AAATATCTTGGGCCTGGGAACA | 22 | 45.45 | 59.87 |
CPV-400_9_RIGHT | 1 | ACTGCTCCATCACTCATTGGTG | 22 | 50.00 | 60.80 |
CPV-400_10_LEFT | 2 | ACCACCTCATATTTTCATCAATCTTGC | 27 | 37.04 | 60.91 |
CPV-400_10_RIGHT | 2 | TCAACCAATGACCAAGGTGTTACA | 24 | 41.67 | 60.95 |
CPV-400_11_LEFT | 1 | GTGGTTGTAAATAATATGGATAAAACTGCA | 30 | 30.00 | 60.00 |
CPV-400_11_RIGHT | 1 | TGTTCTATCCCATTGAAAATAATATCTCCA | 30 | 30.00 | 59.80 |
CPV-400_12_LEFT | 2 | TGCCATTTACTCCAGCAGCTAT | 22 | 45.45 | 60.01 |
CPV-400_12_RIGHT | 2 | TCCCATTTGAGTTACACCACGT | 22 | 45.45 | 60.08 |
CPV-400_13_LEFT | 1 | TTTGCCTCAATCTGAAGGAGCT | 22 | 45.45 | 60.14 |
CPV-400_13_RIGHT | 1 | ATCATTCGTTACAGGAAGGTTAAAGTT | 27 | 33.33 | 59.83 |
CPV-400_14_LEFT | 2 | ACACCTGAGAGATTTACATATATAGCACA | 29 | 34.48 | 60.63 |
CPV-400_14_RIGHT | 2 | ACCTTTCCACCAAAAATCTGAGTAAG | 26 | 38.46 | 60.18 |
CPV-400_15_LEFT | 1 | CAAATGGTCAAATTTGGGATAAAGAATTTG | 30 | 30.00 | 60.15 |
CPV-400_15_RIGHT | 1 | TTCTAGGTGCTAGTTGATATGTAATAAACA | 30 | 30.00 | 59.56 |
CPV-400_16_LEFT | 2 | TGTTTATTACATATCAACTAGCACCTAGAA | 30 | 30.00 | 59.56 |
CPV-400_16_RIGHT | 2 | TCTAAGGGCAAACCAACCAACC | 22 | 50.00 | 61.20 |
CPV-400_17_LEFT | 1 | AGGTTTGTTAGATGGTATACAATAACTGT | 29 | 31.03 | 59.61 |
CPV-400_17_RIGHT | 1 | AGCTTTAAATACTAATTTACCTTTCCACCA | 30 | 30.00 | 60.50 |
CPV-400_17.5_RIGHT* | 1 | AAGTATCAATCTGTCTTTAAGGGG | 24 | 37.50 | 60.10 |
CPV-400_18_LEFT* | 2 | TATAAGGTGAACTAACCTTACCATA | 25 | 32.00 | 59.20 |
CPV-400_18_RIGHT* | 2 | TTAATATAATTTTCTAGGTGCTAGTTG | 27 | 25.90 | 59.20 |
Table 1. Primers targeting 400 bp amplicons
A | B | C | D | E | F |
---|---|---|---|---|---|
CPV-1000_1_LEFT | 1 | CTGACCAAGTTCACGTACGTATGA | 24 | 45.83 | 60.93 |
CPV-1000_1_RIGHT | 1 | TGTTCAGTGTAAAGTGTGCTGACA | 24 | 41.67 | 61.18 |
CPV-1000_2_LEFT | 2 | GTGAATGGGTGACTATATTAACATACAGAC | 30 | 36.67 | 60.73 |
CPV-1000_2_RIGHT | 2 | ACCAAACCAAAGTCTCCTGGAAG | 23 | 47.83 | 60.95 |
CPV-1000_3_LEFT | 1 | AAGCAAATTGAACCAACTCCAGT | 23 | 39.13 | 59.55 |
CPV-1000_3_RIGHT | 1 | GGTGGTGGTTTACTTCTTTTAGTTGG | 26 | 42.31 | 60.90 |
CPV-1000_4_LEFT | 2 | CTAAGGACGCTAAAGATTGGGGG | 23 | 52.17 | 61.00 |
CPV-1000_4_RIGHT | 2 | GTTCCTGTAGCAAATTCATCACCTG | 25 | 44.00 | 60.77 |
CPV-1000_5_LEFT | 1 | CCATCTCATACTGGAACTAGTGGC | 24 | 50.00 | 60.82 |
CPV-1000_5_RIGHT* | 1 | TGGATTCCAAGTATGAGAGGCTCT | 24 | 45.83 | 61.21 |
CPV-1000_6_LEFT | 2 | AACCAAGACTTCATGTAAATGCACC | 25 | 40.00 | 60.66 |
CPV-1000_6_RIGHT* | 2 | TGGATTCCAAGTATGAGAGGCTCT | 24 | 45.83 | 61.21 |
Table 2. Primers targeting 1000 bp amplicons
We used
Reactions should be set up independent for each pool , with a final volume of 25µL
, as bellow:
Reactions for 400 bp products:
* Master Mix 2X - `12.5µL`
* Primer pool 1 **or** 2 - `1.6µL`
* Nuclease-free H20 - `5.9µL`
* DNA - `5.0µL`
Reactions for 1000 bp products:
* Master Mix 2X - `12.5µL`
* Primer pool 1 **or** 2 - `0.4µL`
* Nuclease-free H20 - `7.1µL`
* DNA - `5.0µL`
The final concentration in a reaction should be 15nanomolar (nM)
per primer. Therefore, the volume of primers used in a reaction will vary according with the number of primers in the pool. More about this subject can be found in Quick et al. (2017).
PCR's run method should be set as:
* `98°C` for `0h 3m 0s`
* 35 cycles of (`98°C` for `0h 0m 15s`; `63°C` for `0h 5m 0s`)
* Hold at `4°C`
Purifying PCR Products with AMPure XP beads (Beckman Coulter)
Mix amplification products of Pool 1 and Pool 2 (final volume 50µL
).
We purify the fragments with
This is step can also be fast-tracked by the use of an automated system.
Add an equal volume of AMPure XP per sample (50µL
).
After biding, on a magnetic stand, wash beads once with 80% (v/v)
ethanol.
Elute DNA with 20µL
of (sequencing appropriate) buffer.
Transfer DNA to a new plate/tube.
Quantify your DNA.
We used
Equipment
Value | Label |
---|---|
Qubit™ 3 Fluorometer | NAME |
Fluorometer for nucleic acid quantitation | TYPE |
Invitrogen | BRAND |
Q33216 | SKU |
Fluorometer for nucleic acid quantitation | SPECIFICATIONS |
Library preparation & sequencing
To prepare a library, use the Ligation and Barcoding kits (following manufacturer's instructions).
We used Ligation Sequencing kit SQK-LSK-109 and Native Barcoding kits EXP-NBD104 and EXP-NBD114 (Oxford Nanopore)
Load library on your flow cell and sequence your sample.
We used R9.4 Oxford MinION flow cell (FLO-MIN106) and MinION Mk1B device for sequencing.